혈관내 초음파 시장 규모, 점유율 및 동향 분석 보고서 : 양식별, 제품별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Intravascular Ultrasound Market Size, Share & Trends Analysis Report By Modality (Mercury-based, Mercury-free), By Product (Pediatric, Adults), End Use (Ear, Forehead), By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,134,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,501,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,235,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

혈관내 초음파 시장의 성장과 동향

세계 혈관내 초음파 시장 규모는 2030년 11억 4,710만 달러로 추정되며, 2024-2030년간 연평균 5.2% 성장할 것으로 예상됩니다.

심혈관 질환의 유병률 증가와 효과적인 진단 기술에 대한 수요 증가가 시장을 이끄는 주요 요인입니다. 또한, 지속적인 기술 발전은 예측 기간 동안 시장 성장을 더욱 촉진할 것으로 예상됩니다. 혈관내 초음파(IVUS)는 X선 기술을 사용하여 이미지를 생성하는 혈관 조영술의 많은 단점을 극복하는 기술이기 때문에 효과적인 혈관 내 영상 촬영 방식입니다.

또한, 고급 의료 영상에 대한 수요 증가는 인공지능(AI)의 급속한 발전으로 이어지고 있습니다. 예를 들어, 2021년 3월 GE 헬스케어는 업계 최초로 심장 영상용 AI 도구와 함께 휴대용 POCUS(Point-of-Care Ultrasound Device)인 Venue Fit을 출시했습니다. 선진국의 관상동맥 중재시술에 대한 유리한 보험급여 정책은 예측 기간 동안 업계 성장을 더욱 촉진할 것으로 예상됩니다. 미국 메디케어 및 메디케이드 서비스 센터(CMS)는 다양한 심혈관 시술에 대해 유리한 의료 보험 정책을 제공합니다.

이러한 서비스를 선택하는 환자들이 늘어날 가능성이 있습니다. 일부 유명 기업들은 제품 포트폴리오를 확장하고 제조 능력을 강화하기 위해 자금 조달, 중소 기업 인수 등 다양한 노력을 기울이고 있습니다. 예를 들어, 2020년 8월 Philips는 심혈관 초음파 시스템 Affiniti CVx를 출시했습니다. 이 솔루션은 순환기과가 효율성과 처리량을 개선하고 더 많은 환자에게 더 나은 치료를 제공할 수 있도록 설계되었습니다.

혈관내 초음파 시장 보고서 하이라이트

• 모달리티별로는 심장학 분야의 광범위한 응용 분야와 우위성으로 인해 가상 조직 IVUS 부문이 2022년 가장 큰 매출 점유율을 차지할 것으로 예상됩니다.
• 제품별로는 2022년 액세서리 부문이 가장 큰 매출 점유율을 차지했습니다. 이 부문은 카테터, 가이드와이어 및 기타로 세분화됩니다.
• 진단센터의 최종 용도 부문은 예측 기간 동안 가장 빠른 성장률을 나타낼 것으로 예상됩니다.
• 이러한 성장은 독립형 진단센터 설립이 증가하고 있기 때문입니다.
• 아시아태평양은 2023-2030년 사이 가장 빠른 성장률을 나타낼 것으로 예상됩니다. 이는 대상 환자 인구의 존재, 의료에 대한 인식 증가, R&D 및 향후 연구 프로젝트에 대한 정부 자금 지원 증가에 기인합니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 혈관내 초음파 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 혈관내 초음파 시장 분석 툴
  • 업계 분석 - Porter의 Five Forces 분석
  • PESTEL 분석

제4장 혈관내 초음파 시장 : 모달리티 추정·동향 분석

• 부문 대시보드
• 혈관내 초음파 시장 : 모달리티 변동 분석
• 혈관내 초음파 시장 : 모달리티별 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 버추얼 조직학 IVUS

제5장 혈관내 초음파 시장 : 제품별, 추정·동향 분석

• 부문 대시보드
• 혈관내 초음파 시장 : 제품 변동 분석
• 혈관내 초음파 시장 : 제품별 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 콘솔
• 부속품

제6장 혈관내 초음파 시장 : 최종 용도별, 추정·동향 분석

• 부문 대시보드
• 혈관내 초음파 시장 : 최종 용도 변동 분석
• 혈관내 초음파 시장 : 최종 용도별 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 병원
• 영상진단센터
• 학술연구기관

제7장 혈관내 초음파 시장 : 지역별, 추정·동향 분석

• 지역 대시보드
• 시장 규모, 예측 동향 분석, 2018-2030년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 시장 진출기업 분류
• 주요 기업 개요
  • Chison Medical Technologies
  • Samsung Medison
  • Canon Medical Systems Corp.
  • Boston Scientific Corp.
  • GE Healthcare
  • Philips
  • Siemens Healthcare
  • Hitachi
  • Mindray Medical International Ltd.
  • Fujifilm Corp.

LSH

영문 목차

영문목차

Intravascular Ultrasound Market Growth & Trends:

The global intravascular ultrasound market size was estimated at USD 1147.1 million in 2030 and is projected to grow at a CAGR of 5.2% from 2024 to 2030. The rising prevalence of cardiovascular disorders coupled with the increasing demand for effective diagnostic techniques is the key factor driving the market. Moreover, consistent technological advancements are further expected to boost market growth during the forecast period. Intravascular ultrasound (IVUS) is an effective intravascular imaging modality as this technology overcomes numerous disadvantages of angiography, which utilizes X-ray technology to create images.

Furthermore, the growing demand for advanced and accurate medical imaging is resulting in the rapid development of Artificial Intelligence (AI). For instance, in March 2021, GE Healthcare announced a portable Point-of-Care Ultrasound Device (POCUS) called Venue Fit, in addition to an industry-first AI tool for cardiac imaging. Favorable reimbursement policies for coronary intervention procedures in developed countries are further anticipated to boost industry growth over the forecast period. The Centers for Medicare & Medicaid Services (CMS) offers favorable healthcare insurance policies for various cardiovascular procedures.

This may increase the number of patients opting for such services. Some of the prominent companies in the industry are undertaking different initiatives, such as funding and acquisitions of medium- and small-sized businesses to expand their product portfolios and enhance their manufacturing capacities. For instance, in August 2020, Philips launched Affiniti CVx a cardiovascular ultrasound system. The solution is designed to help cardiology departments provide better care to more patients with enhanced efficiency and throughput.

Intravascular Ultrasound Market Report Highlights:

• Based on modality, the virtual histology IVUS segment accounted for the largest revenue share in 2022 owing to its wide range of applications and advantages in cardiology
• Based on products, the accessories segment held the largest revenue share in 2022. The segment is sub-categorized into catheters, guidewires, and others
• The diagnostic centers end-use segment is anticipated to register the fastest growth rate during the forecast period
• This growth can be attributed to the increasing number of establishments of standalone diagnostic centers
• Asia Pacific is expected to register the fastest growth rate from 2023 to 2030 on account of the presence of the target patient population, increasing healthcare awareness, and rising government funding for R&D & upcoming research projects

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Modality
  • 1.2.2. Product
  • 1.2.3. End use
  • 1.2.4. Regional Scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Modality outlook
  • 2.2.2. Product outlook
  • 2.2.3. End use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Intravascular Ultrasound Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of cardiovascular diseases leading to higher demand for diagnostic and imaging technologies
    • 3.2.1.2. Advancements in IVUS technology
    • 3.2.1.3. Growing adoption of minimally invasive surgical procedures
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of IVUS systems and procedures limiting widespread adoption
    • 3.2.2.2. Limited availability of skilled professionals to operate and interpret IVUS technology
• 3.3. Intravascular Ultrasound Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Intravascular Ultrasound Market: Modality Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Intravascular Ultrasound Market: Modality Movement Analysis
• 4.3. Intravascular Ultrasound Market by Modality Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Virtual Histology IVUS
  • 4.5.1. Virtual Histology IVUS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. iMAP IVUS
    • 4.5.2.1. iMAP IVUS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Integrated Backscatter IVUS
    • 4.5.3.1. Integrated Backscatter IVUS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Intravascular Ultrasound Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Intravascular Ultrasound Market: Product Movement Analysis
• 5.3. Intravascular Ultrasound Market by Product Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Consoles
  • 5.5.1. Consoles Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Accessories
  • 5.6.1. Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.2. Catheters
    • 5.6.2.1. Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.3. Guidewires
    • 5.6.3.1. Guidewires Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.4. Others
    • 5.6.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Intravascular Ultrasound Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Intravascular Ultrasound Market: End Use Movement Analysis
• 6.3. Intravascular Ultrasound Market by End Use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Diagnostic Imaging Centers
  • 6.6.1. Diagnostic Imaging Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Academic And Research Institutes
  • 6.7.1. Academic And Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Intravascular Ultrasound Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Chison Medical Technologies
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Samsung Medison
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Canon Medical Systems Corp.
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Boston Scientific Corp.
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. GE Healthcare
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Philips
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Siemens Healthcare
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Hitachi
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Mindray Medical International Ltd.
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Fujifilm Corp.
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives

관련자료